HAL (France)
open access
From clusters to clinic: An 8-gene signature combined with mucinous component stratifies benefit of anti-CTLA-4 addition to anti-PD-1 in dMMR/MSI-H metastatic colorectal cancer
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Multi-layer molecular profiling defines an immune-active colorectal cancer subtype with therapeutic relevance.#4406
- First-line PD-1 +/- CTLA-4 blockade in patients with deficient mismatch repair and/or microsatellite instability-high metastatic colorectal cancer#322435
- Integrated clinicogenomic analysis reveals the evolution and metastatic tropisms of advanced colorectal cancer.#1054138
- Molecular Characterisation of Colorectal Cancer Peritoneal Metastases#802150
- Niraparib and Dostarlimab for Patients With MMR-D/MSI-H Colorectal Cancers#872895
Record · ID 159304
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive